Stockreport

Pressure BioSciences, Inc. Reports Q3 2022 Financial Results and Offers Business Update on Ultra Shear Technology Nanoemulsions Commercialization Progress

PRESSURE BIOSCIENCES  (PBIO) 
US:NASDAQ Investor Relations: ir.pressurebiosciences.com
PDF Resources Continue to Pivot to UST Platform Commercialization, Achieving Major Progress and Traction; Revolutionary Nanoemulsions Technology Expected to Drive Major Grow [Read more]